Boston, MA 04/14/2014 (wallstreetpr) – The Rite Aid Corporation (NYSE:RAD) had difficult time in the past but has bounced backed from it. Since then, the company has been harvesting profits. Will this continue? If yes, for how long will it flourish? There are many things to determine and predict and see if they hold good.
Rite has been moving towards growth and progress this year. It has been a good time for earnings for the company. It remains to be seen whether Rite will be able to maintain this success or not. It will be tragic if the good times turn out to be short-lived.
Impressive profits
Rite Aid Corporation (NYSE:RAD) had impressive profits last year, and this year too has been a good start. The returns have been solid since January, 2014. In fact, an amazing long-term benefit awaits Rite because of the current rise of generic drugs. Reportedly a lot of popular drugs have now ended their patents and have gone generic. Rite will surely profit from this because now it will have to pay less.
But then again it will have to face some tough competition from its two major rivals. Pricing in such a way so as to make their drugs seem cheaper and more reasonable than its competitors could be a challenge for Rite Aid.
Aid health alliance
Reportedly Rite Aid has been working on growing an alliance between its health care providers and its pharmacies. This project is expected to allow consumers to easily communicate with their physicians. This service is currently available across three cities namely Los Angeles, Buffalo and Greensboro. This service will revolutionize the pharmacy service. It represents a brilliant effort on the part of Rite Aid. Lets keep our fingers crossed and hope that this helps Rite Aid Corporation (NYSE:RAD) to maintain the turnaround that it has been having.
